Sun Life Financial’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-4,531
| Closed | -$293K | – | 243 |
|
|
2021
Q1 | $293K | Buy |
4,531
+3,789
| +511% | +$245K | 0.03% | 94 |
|
|
2020
Q4 | $43K | Sell |
742
-6
| -0.8% | -$348 | 0.01% | 178 |
|
|
2020
Q3 | $47K | Sell |
748
-10,531
| -93% | -$662K | 0.01% | 164 |
|
|
2020
Q2 | $868K | Sell |
11,279
-84
| -0.7% | -$6.46K | 0.17% | 40 |
|
|
2020
Q1 | $849K | Buy |
11,363
+2,289
| +25% | +$171K | 0.21% | 25 |
|
|
2019
Q4 | $590K | Sell |
9,074
-5,043
| -36% | -$328K | 0.16% | 75 |
|
|
2019
Q3 | $895K | Buy |
14,117
+6,512
| +86% | +$413K | 0.23% | 69 |
|
|
2019
Q2 | $514K | Sell |
7,605
-8,419
| -53% | -$569K | 0.13% | 93 |
|
|
2019
Q1 | $1.04M | Buy |
16,024
+12,446
| +348% | +$809K | 0.23% | 70 |
|
|
2018
Q4 | $224K | Buy |
3,578
+21
| +0.6% | +$1.32K | 0.05% | 178 |
|
|
2018
Q3 | $275K | Buy |
3,557
+34
| +1% | +$2.63K | 0.05% | 186 |
|
|
2018
Q2 | $250K | Buy |
3,523
+3,073
| +683% | +$218K | 0.04% | 192 |
|
|
2018
Q1 | $5.97K | Sell |
450
-5,406
| -92% | -$71.7K | 0.05% | 131 |
|
|
2017
Q4 | $420K | Sell |
5,856
-6,757
| -54% | -$485K | 0.04% | 116 |
|
|
2017
Q3 | $1.02M | Buy |
12,613
+157
| +1% | +$12.7K | 0.1% | 77 |
|
|
2017
Q2 | $882K | Buy |
12,456
+12,204
| +4,843% | +$864K | 0.09% | 78 |
|
|
2017
Q1 | $3.71K | Buy |
252
+202
| +404% | +$2.97K | 0.01% | 90 |
|
|
2016
Q4 | $703 | Buy |
+50
| New | +$703 | 0.01% | 99 |
|